SCHEMBL19631461

SCHEMBL19631461

Cc1sc(N/N=C/c2ccccc2C(=O)O)nc1-c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 5/20 1.00
▸ MAOA P21397 11/20 0.61
▸ MAOB P27338 10/20 0.61
▸ MEN1 O00255 6/20 0.60
▸ KMT2A Q03164 6/20 0.60
▸ MAPT P10636 5/20 0.60
▸ GAA P10253 4/20 0.60
▸ LMNA P02545 2/20 0.60
▸ RAB9A P51151 1/20 0.60
▸ SMN1; SMN2 Q16637 2/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58
▸ CYP1A2 P05177 2/20 0.57
▸ CYP2C19 P33261 2/20 0.57
▸ ALDH1A1 P00352 2/20 0.57
▸ CYP2D6 P10635 1/20 0.57
▸ CYP2C9 P11712 1/20 0.57
▸ HTT P42858 1/20 0.57
▸ GSTO1 P78417 1/20 0.52
▸ ALOX5 P09917 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28343270 1.00 DHODH (1.00) DHODHMAOAMAOBMEN1KMT2A
SCHEMBL29859512 1.00 DHODH (1.00) DHODHMAOAMAOBMEN1KMT2A
SCHEMBL25613763 0.92 DHODH (0.85) DHODHMAOAMAOBMEN1KMT2A
SCHEMBL28343266 0.86 DHODH (1.00) DHODHMAOAMAOBMEN1KMT2A
SCHEMBL29859393 0.86 DHODH (1.00) DHODHMAOAMAOBMEN1KMT2A
SCHEMBL19631430 0.86 DHODH (1.00) DHODHMAOAMAOBMEN1KMT2A
SCHEMBL25613721 0.84 DHODH (0.72) DHODHMAOAMAOBMEN1KMT2A
SCHEMBL25614403 0.82 DHODH (0.70) DHODHMAOAMAOBMEN1KMT2A
SCHEMBL21391548 0.78 DHODH (0.64) DHODHMAOAMAOBMEN1KMT2A
SCHEMBL19631441 0.76 DHODH (1.00) DHODHMAOAMAOBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230190713-A1 ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2023-06-22 — — US disclosed
US-20230190713-A1 ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2023-06-22 — — US disclosed
US-11590109-B2 Applications of novel thiazole derivative in treating virus infection INSTITUT PASTEUR OF SHANGHAI, CHINESE ACADEMY OF SCIENCES (CN) 2023-02-28 — — US disclosed
US-11590109-B2 Applications of novel thiazole derivative in treating virus infection INSTITUT PASTEUR OF SHANGHAI, CHINESE ACADEMY OF SCIENCES (CN) 2023-02-28 — — US disclosed
EP-4116296-A1 ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF East China University of Science and Technology (CN) 2023-01-11 — — EP disclosed
US-11534427-B2 Applications of novel thiazole derivative in treating inflammatory bowel diseases EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2022-12-27 — — US disclosed
US-11534427-B2 Applications of novel thiazole derivative in treating inflammatory bowel diseases EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2022-12-27 — — US disclosed
CN-107375279-B Use of novel thiazole derivatives for the treatment of inflammatory bowel disease 华东理工大学 2022-11-01 — — CN disclosed
CN-107382902-B Thiazole derivative and application thereof 华东理工大学 2022-08-12 — — CN disclosed
CN-107459496-B Use of thiazole derivatives for treating viral infections 华东理工大学 2022-07-19 — — CN disclosed
US-20190290620-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-09-26 — — US disclosed
US-20190292162-A1 THIAZOLE DERIVATIVE AND APPLICATIONS EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-09-26 — — US disclosed
US-20190292162-A1 THIAZOLE DERIVATIVE AND APPLICATIONS EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-09-26 — — US disclosed
US-20190134008-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING VIRUS INFECTION EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-05-09 — — US disclosed
US-20190134008-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING VIRUS INFECTION EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-05-09 — — US disclosed
EP-3459937-A1 THIAZOLE DERIVATIVE AND APPLICATIONS East China University of Science and Technology (CN) 2019-03-27 — — EP disclosed
EP-3459937-A1 THIAZOLE DERIVATIVE AND APPLICATIONS East China University of Science and Technology (CN) 2019-03-27 — — EP disclosed
WO-2017206955-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING VIRUS INFECTION 华东理工大学 2017-12-07 — — WO disclosed
WO-2017198178-A1 THIAZOLE DERIVATIVE AND APPLICATIONS 华东理工大学 2017-11-23 — — WO disclosed
WO-2017198179-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES 华东理工大学 2017-11-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11534427-B2 Applications of novel thiazole derivative in treating inflammatory bowel diseases FABP2, SLC10A2, ALPI DHODH 803/4885MAOA 4074/4885MAOB 3732/4885
US-20190292162-A1 THIAZOLE DERIVATIVE AND APPLICATIONS DHODH, DLD, THOC2 DHODH 1/4885MAOA 880/4885MAOB 746/4885
US-20190290620-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES FABP2, SLC10A2, ALPI DHODH 803/4885MAOA 4074/4885MAOB 3732/4885
US-11590109-B2 Applications of novel thiazole derivative in treating virus infection HAVCR2, MAVS, EIF2AK2 DHODH 1507/4885MAOA 4580/4885MAOB 4294/4885
US-20190134008-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING VIRUS INFECTION HAVCR2, MAVS, EIF2AK2 DHODH 1507/4885MAOA 4580/4885MAOB 4294/4885
US-20230190713-A1 ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF SARS1, EIF2AK2, NSUN3 DHODH 2268/4885MAOA 4585/4885MAOB 4626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback